Actuate Therapeutics Inc (ACTU): Hedge Fund Ownership & Smart Money Signals (Q1 2026)

Q: Is it too late to buy Actuate Therapeutics Inc (ACTU) following the 2026 Q1 hedge fund 13F filings?

As of today, ACTU has moved -22.9% since the 2026 Q1 13F filing date (May 15, 2026), compared to +6.0% for the XLV sector ETF — an outperformance of -28.9%. Since the quarter end (March 31, 2026), ACTU gained -26.3% vs +4.9% for XLV. The stock is tracking its sector benchmark closely. The signal remains fresh and the entry point is still near the fund's implied reference.

Actuate Therapeutics Inc (ACTU)

58 + Investors. Track Smart Money conviction in ACTU. See who's accumulating, reducing, or initiating positions.

Smart Money Signals — ACTU

Based on 59 hedge funds · latest filing: 2026 Q1 · updated quarterly

📈

Buying streak — 6 quarters in a row

last 6Q

For 6 consecutive quarters, more hedge funds added ACTU than sold it. That's a consistent pattern of professional buying — not a one-time trade. When institutions keep buying quarter after quarter, it usually means they see a multi-year opportunity, not just a short-term momentum flip.

📊

High ownership — 79% of 3.0Y peak

79% of all-time peak

59 funds currently hold this stock — 79% of the 3.0-year high of 75 funds (reached 2013 Q4). Ownership is elevated but not yet at maximum concentration. Room to grow, but watch if the trend reverses.

🚀

Fast accumulation — +136% more funds vs a year ago

fund count last 6Q

+34 new funds entered over the past year (+136% YoY). That's a rapid rush of institutional money. Fast accumulation often signals a major thesis — but it also means the stock could fall quickly if that thesis breaks.

🟢

More buyers than sellers — 71% buying

40 buying16 selling

Last quarter: 40 funds were net buyers (22 opened a brand new position + 18 added to an existing one). Only 16 were sellers (10 trimmed + 6 sold completely). A clear majority buying is a strong confirmation signal.

📈

More new buyers each quarter (+14 vs last Q)

new funds entering per quarter

Funds opening a new ACTU position: 19 → 7 → 8 → 22. A growing influx of new institutional buyers means the asset is still gathering momentum — the consensus hasn't fully saturated yet.

📌

Mixed — 37% long-term, 44% new

■ 37% conviction (2yr+) ■ 19% medium ■ 44% new

Of the 59 current holders: 22 (37%) held >2 years, 11 held 1–2 years, and 26 entered in the last year. A mixed base — the stock has long-term believers but also recent buyers who haven't been tested by a downturn yet.

💎

Buying through price weakness — shares +6%, value -53%

Value

-52%

+5%

Last quarter: funds added +6% more shares while total portfolio value only changed -53%. Institutions were buying while the price was falling — a high-conviction accumulation signal. They're deliberately loading up on the dip.

📈

Growing discovery — still being found

9 → 19 → 7 → 8 → 22 new funds/Q

New funds entering each quarter: 19 → 7 → 8 → 22. A growing number of institutions are discovering ACTU each quarter. The narrative is still spreading — leaving room for ongoing capital accumulation.

🌱

Early stage — 56% of holders entered in last year

■ 39% veterans ■ 5% 1-2yr ■ 56% new

Of 59 current holders: 33 (56%) entered in the past year, only 23 (39%) are 2+ year veterans. This is an early-phase institutional idea — still being discovered. High upside potential if the thesis plays out, but thin conviction base.

📋

Smaller funds dominant — 4% AUM from top-100

4% from top-100 AUM funds

22 of 59 holders rank in the top 100 by AUM, but together hold only 4% of total institutional value. The stock is held primarily by smaller and mid-sized funds.

4.1

out of 10

Moderate Exit Risk

Exit risk score 4.1/10 — some crowding factors present, but no critical concentration. Watch ownership trend over the next 1–2 quarters for direction.

Methodology note: these Smart Money cards use consecutive 13F disclosure snapshots, not trade-by-trade execution data. "Buying", "selling", "new holders", and "trimmed" refer to quarter-over-quarter changes in reported holders, aggregate shares, or disclosed position values between filings. They are useful for ownership regime analysis and crowding, but they do not imply exact trade timing on the filing date.

Metric	All 13F Filers (2026 Q1)	Prior (2025 Q4)	Change
Funds Holding	58	43	34.88%
13F Shares	14M	13M	5.77%
Total Value	$38M	$81M	-52.88%
New Positions	21	8	+13
Increased Positions	18	22	-4
Closed Positions	6	6	-
Reduced Positions	10	7	+3
Total Calls	0	0	-
Total Puts	0	0	-
PUT/CALL Ratio	0.0	0.0	Bullish

Metric

All 13F Filers (2026 Q1)

Prior (2025 Q4)

Change

Funds Holding

34.88%

13F Shares

14M

13M

5.77%

Total Value

$38M

$81M

-52.88%

New Positions

+13

Increased Positions

-4

Closed Positions

Reduced Positions

Total Calls

Total Puts

PUT/CALL Ratio

0.0

Bullish

Institutional Holders (2026 Q1)

58 + investors

Explore institutional interest and hedge fund ownership dynamics. Analyze portfolio weights, new positions, and conviction trends in ACTU. Verified SEC 13F-HR filings.

QUARTER:

FILTER:All New Added To Reduced No Change | Overweight >5%

Top 25 ACTU holders by conviction (% of portfolio weight) — 2026 Q1 · Source: SEC Form 13F
#	Investor	% of Portfolio	Shares	Mkt Value
1	BIOS Capital Management, LP	52.09%	10,049,996	$27.5M
2	Connective Capital Management, LLC	0.26%	113,266	$310K
3	Voss Capital, LP	0.25%	1,725,000	$4.7M
4	Palogic Value Management, L.P.	0.12%	100,000	$274K
5	ABS Direct Equity Fund LLC	0.10%	50,000	$137K
6	Texas Capital Bank Wealth Management Services Inc	0.02%	94,592	$259K
7	Rock Creek Group LLC	0.01%	39,263	$108K
8	Sfmg, LLC	0.01%	33,000	$90K
9	Gleason Group, Inc.	0.01%	19,028	$52K
10	Bridgeway Capital Management, LLC	0.00%	30,982	$85K
11	XTX Topco Ltd	0.00%	15,118	$41K
12	Tower Research Capital LLC (TRC)	0.00%	5,754	$16K
13	Northwestern Mutual Wealth Management Co	0.00%	31,396	$86K
14	Ameritas Investment Partners, Inc.	0.00%	601	$2K
15	Essential Partners LLC	0.00%	48	—
16	Vanguard Fiduciary Trust Co	0.00%	62,592	$172K
17	GAMMA Investing LLC	0.00%	286	—
18	Aqr Capital Management LLC	0.00%	27,109	$74K
19	Deutsche Bank Ag\	0.00%	36,398	$100K
20	Vanguard Capital Management LLC	0.00%	400,529	$1.1M
21	New York State Common Retirement Fund	0.00%	6,200	$17K
22	Rhumbline Advisers	0.00%	9,354	$26K
23	BlackRock, Inc.	0.00%	427,153	$1.2M
24	MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd.	0.00%	4,525	$12K
25	Wealth Preservation Advisors, LLC	0.00%	7	—

Investor	Ownership History	% of Portfolio	Prev %	Rank	Conviction	Avg Buy Price	13F Score™ 3Y / 7Y	Sell Timing	Shares	Mkt Value	Change	Change %	Source	Quarter	Filed

Frequently Asked Questions — Actuate Therapeutics Inc (ACTU)

What does the Smart Money Trend signal show for ACTU?

Buying streak — 6 quarters in a row: For 6 consecutive quarters, more hedge funds added ACTU than sold it. That's a consistent pattern of professional buying — not a one-time trade. When institutions keep buying quarter after quarter, it usually means they see a multi-year opportunity, not just a short-term momentum flip.

What is the institutional breadth score for ACTU?

More buyers than sellers — 71% buying: Last quarter: 40 funds were net buyers (22 opened a brand new position + 18 added to an existing one). Only 16 were sellers (10 trimmed + 6 sold completely). A clear majority buying is a strong confirmation signal.

What is the fund quality score for ACTU holders?

Smaller funds dominant — 4% AUM from top-100: 22 of 59 holders rank in the top 100 by AUM, but together hold only 4% of total institutional value. The stock is held primarily by smaller and mid-sized funds.

How long have hedge funds held ACTU?

Mixed — 37% long-term, 44% new: Of the 59 current holders: 22 (37%) held >2 years, 11 held 1–2 years, and 26 entered in the last year. A mixed base — the stock has long-term believers but also recent buyers who haven't been tested by a downturn yet.

Is it too late to buy Actuate Therapeutics Inc (ACTU) following the 2026 Q1 hedge fund 13F filings?

As of today, ACTU has moved -22.9% since the 2026 Q1 13F filing date (May 15, 2026), compared to +6.0% for the XLV sector ETF — an outperformance of -28.9%. Since the quarter end (March 31, 2026), ACTU has gained -26.3% vs +4.9% for XLV. The stock is tracking its sector benchmark closely. The signal remains fresh and the entry point is still near the fund's implied reference.

Where does this institutional ownership data come from?

All holdings data is sourced from SEC Form 13F filings, which institutional investment managers with over $100 million in assets are required to submit quarterly. Data is parsed directly from SEC EDGAR.

Market Cap	--
Enterprise Value	--
Trailing P/E	--
Forward P/E	--
PEG Ratio (5yr expected)	--
Price/Sales (ttm)	--
Price/Book (mrq)	--
Enterprise Value/Revenue	--
Enterprise Value/EBITDA	--
Beta (5Y Monthly)	--
Short Ratio (Days to Cover)	--
Short % of Float	--

Profit Margin	--
Return on Assets (ttm)	--
Return on Equity (ttm)	--

Revenue (ttm)	--
Net Income Avi to Common (ttm)	--
Diluted EPS (ttm)	--
Total Cash (mrq)	--
Total Debt/Equity (mrq)	--
Levered Free Cash Flow (ttm)	--

Actuate Therapeutics Inc (ACTU)

Smart Money Signals — ACTU

Buying streak — 6 quarters in a row

High ownership — 79% of 3.0Y peak

Fast accumulation — +136% more funds vs a year ago

More buyers than sellers — 71% buying

More new buyers each quarter (+14 vs last Q)

Mixed — 37% long-term, 44% new

Buying through price weakness — shares +6%, value -53%

Growing discovery — still being found

Early stage — 56% of holders entered in last year

Smaller funds dominant — 4% AUM from top-100

Institutional Sentiment Summary — ACTU

Hedge Fund Ownership: ACTU

Market Analysis: ACTU

Analyst Price Targets

Analyst Recommendations

Stock Performance

Company Profile: ACTU

Is It Too Late to Buy Actuate Therapeutics Inc (ACTU) Based on Hedge Fund 13F Filings?

Hedge Fund Positioning: ACTU

Statistics: ACTU

Valuation Measures Data as of: --

Financial Highlights

Institutional Holders (2026 Q1)

Frequently Asked Questions — Actuate Therapeutics Inc (ACTU)

Welcome to 13Foresight!